# Machine learning models for early mortality prediction in severe fever with thrombocytopenia syndrome

**Authors:** Chenxi Zhao, Tingyu Zhang, Ziruo Ge, Ling Lin, Di Tian, Yi Shen, Zhenghua Zhao, Jingxia Wang, Jianming Lai, Yanli Xu, Jianping Duan, Zhihai Chen

PMC · DOI: 10.1016/j.isci.2026.114843 · iScience · 2026-01-29

## TL;DR

This study developed an AI model to predict early mortality in a severe viral disease, using data from over 1,600 patients and deploying a web tool for real-time risk assessment.

## Contribution

A novel interpretable machine learning model for early mortality prediction in SFTS, validated across multiple hospitals and deployed as an open-access web tool.

## Key findings

- The XGBoost model achieved high accuracy (AUC of 0.916 in training and 0.905 in validation).
- SHAP analysis identified six key predictors of mortality in SFTS patients.
- A real-time web-based tool was developed to provide individualized risk predictions with visual explanations.

## Abstract

Severe fever with thrombocytopenia syndrome (SFTS) is a high-fatality viral disease where early mortality risk prediction is vital for clinical management. This retrospective multicenter cohort study enrolled 1,690 hospitalized SFTS patients from five Chinese hospitals (2014–2023) to develop, validate, and deploy an interpretable machine learning (ML) model for early mortality risk assessment. Using LASSO regression for feature selection then comparing eight ML algorithms, the XGBoost model achieved an AUC of 0.916 in the training cohort and 0.905 in the temporal validation cohort. SHapley Additive exPlanations (SHAP) analysis identified six key predictors, which were used to deploy a real-time, open-access web-based tool (https://sftsprognosis.com) that provides individualized risk predictions with visual explanations. The XGBoost model has the potential to enhance timely clinical decision-making, facilitate efficient allocation of critical care resources, and provide a generalizable framework for applying machine learning in the management of emerging infectious diseases.

•This retrospective multicentre cohort study collected 10 years from five hospitals in China•Eight machine learning models were trained, validated, and interpreted using SHAP analysis•An XGBoost model was developed to predict early mortality risk in patients with SFTS•A publicly accessible, real-time web tool was deployed to facilitate timely decision-making

This retrospective multicentre cohort study collected 10 years from five hospitals in China

Eight machine learning models were trained, validated, and interpreted using SHAP analysis

An XGBoost model was developed to predict early mortality risk in patients with SFTS

A publicly accessible, real-time web tool was deployed to facilitate timely decision-making

Public health; Artificial intelligence applications

## Full-text entities

- **Genes:** CMPK1 (cytidine/uridine monophosphate kinase 1) [NCBI Gene 51727] {aka CK, CMK, CMPK, UMK, UMP-CMPK, UMPK}, SHROOM4 (shroom family member 4) [NCBI Gene 57477] {aka MRXSSDS, SHAP, shrm4}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, ALPP (alkaline phosphatase, placental) [NCBI Gene 250] {aka ALP, PALP, PLAP, PLAP-1}, GGT1 (gamma-glutamyltransferase 1) [NCBI Gene 2678] {aka CD224, D22S672, D22S732, GGT, GGT 1, GGTD}, GGTLC5P (gamma-glutamyltransferase light chain 5 pseudogene) [NCBI Gene 653590] {aka GGT}, BCHE (butyrylcholinesterase) [NCBI Gene 590] {aka BCHED, CHE1, CHE2, E1}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** lymphadenopathy (MESH:D008206), cytokine abnormalities (MESH:D000080424), leukopenia (MESH:D007970), nausea (MESH:D009325), multi-organ failure (MESH:D009102), renal impairment (MESH:D007674), hemorrhagic (MESH:D006470), fatigue (MESH:D005221), ML (MESH:D007859), myalgia (MESH:D063806), personality changes (MESH:D010554), diarrhea (MESH:D003967), liver dysfunction (MESH:D017093), Neurological abnormalities (MESH:D009461), seizures (MESH:D012640), fever (MESH:D005334), DIC (MESH:D004211), SFTS (MESH:D000085142), Infectious Disease (MESH:D003141), vomiting (MESH:D014839), gastrointestinal symptoms (MESH:D012817), headache (MESH:D006261), hepatic and renal dysfunction (MESH:D008107), seizure disorder (MESH:D004827), platelet disorders (MESH:D001791), hematologic disorders (MESH:D006402), impaired consciousness (MESH:D003244), hemostatic abnormalities (MESH:D020141), death (MESH:D003643), viral disease (MESH:D014777), leukemia (MESH:D007938), coagulation abnormalities (MESH:D001778), infections (MESH:D007239), weakness (MESH:D018908), COVID-19 (MESH:D000086382), atrial fibrillation (MESH:D001281), diabetes (MESH:D003920), thrombocytopenia (MESH:D013921), malignant tumors (MESH:D009369), chill (MESH:D023341), arthralgia (MESH:D018771), lethargy (MESH:D053609), tick-borne infectious disease (MESH:D017282), LDH (MESH:C538133), acute pancreatitis (MESH:D010195)
- **Chemicals:** ribavirin (MESH:D012254), urea nitrogen (MESH:C530477), creatinine (MESH:D003404), DBiL (-), D- (MESH:D003903), bile acid (MESH:D001647), K+ (MESH:D011188), Na+ (MESH:D012964), favipiravir (MESH:C462182), TBiL (MESH:D001663)
- **Species:** Severe fever with thrombocytopenia syndrome virus (no rank) [taxon 1003835], Mustela putorius furo (black ferret, subspecies) [taxon 9669], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12936484/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12936484/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC12936484/full.md

---
Source: https://tomesphere.com/paper/PMC12936484